Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.
Breast Cancer Research and Treatment|July 4, 2009
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimensJosé Alejandro Pérez-Fidalgo, Susana Roselló, Elisa García-Garré, et al.
Breast Cancer : Basic and Clinical Research|March 1, 2019
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic IndicatorMaría Teresa Martínez, Sara S Oltra, María Peña-Chilet, et al.
The Oncologist|February 3, 2019
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position StatementRamon Colomer, Cristina Saura, Pedro Sánchez-Rovira, et al.
Critical Reviews in Oncology/Hematology|August 31, 2015
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literatureMaría Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell, et al.
ACS Sensors|February 18, 2021
Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic ToolIris Garrido-Cano, Luis Pla, Sara Santiago-Felipe, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Plos One|April 2, 2013
rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibilityMaria Peña-Chilet, Maider Ibarrola-Villava, Manuel Martin-González, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancerJoan Climent, Jose A Martinez-Climent, David Blesa, et al.
Cancer Research|January 20, 2007
Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancerJoan Climent, Peter Dimitrow, Jane Fridlyand, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.
Breast Cancer Research and Treatment|July 4, 2009
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimensJosé Alejandro Pérez-Fidalgo, Susana Roselló, Elisa García-Garré, et al.
Breast Cancer : Basic and Clinical Research|March 1, 2019
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic IndicatorMaría Teresa Martínez, Sara S Oltra, María Peña-Chilet, et al.
The Oncologist|February 3, 2019
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position StatementRamon Colomer, Cristina Saura, Pedro Sánchez-Rovira, et al.
Critical Reviews in Oncology/Hematology|August 31, 2015
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literatureMaría Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell, et al.
ACS Sensors|February 18, 2021
Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic ToolIris Garrido-Cano, Luis Pla, Sara Santiago-Felipe, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Plos One|April 2, 2013
rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibilityMaria Peña-Chilet, Maider Ibarrola-Villava, Manuel Martin-González, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancerJoan Climent, Jose A Martinez-Climent, David Blesa, et al.
Cancer Research|January 20, 2007
Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancerJoan Climent, Peter Dimitrow, Jane Fridlyand, et al.
Pageof 19